PACLITAXEL, Durvalumab_IJB, CARBOPLATIN, Oleclumab_IJB
IJB-SYNERGY-012017
Phase 2 small_molecule active
Quick answer
PACLITAXEL, Durvalumab_IJB, CARBOPLATIN, Oleclumab_IJB for Previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active